Renovaro Inc. - Common Stock (NQ: RENB )
0.8089
+0.0669
(+9.02%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about Renovaro Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/10/20/image21.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
October 20, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
![](https://mms.businesswire.com/media/20231005194413/en/1115287/22/Latest_KSF_M%26A.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/10/04/image14.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
![](https://mms.businesswire.com/media/20230929188403/en/1567526/5/Firm_Logo-with_Investor_Law_Firm.jpg)
![](https://ml.globenewswire.com/media/25c79e82-0148-4a7e-beb5-e0c67d2e108f/small/main-png.png)
Why Colon Cancer Is Largely Unresponsive to Immunotherapy
September 22, 2023
UI Research Suggests Immune System Can Be Trained to Combat Solid Tumors
September 18, 2023
Stack Foundation Gives UC San Diego $5M Gift to Advance Gene Therapy
September 12, 2023
Tracking Off-Label Cancer Treatment Could Ease Future Trials, Remedies
September 06, 2023
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.